𝛼SK or Search

ENTITY

Curis Inc (CRIS US)

4

Analysis

Health Care • United States

Curis, Inc. operates as a biotechnology company. The Company develops therapeutics for the regeneration and restoration of human tissues and organs. Curis offers drug candidates for the treatment of human cancers. Curis serves customers in the United States.

more

Refresh

Exchange Announcement • 15 Aug 2026 04:02

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 14 Aug 2026 05:27

424B4 | Prospectus

Exchange Announcement • 11 Aug 2026 05:30

S-1 | IPO Registration

Exchange Announcement • 31 Jul 2026 04:01

Current Report (Form 8-K | Period ending 2026-07-24)

Exchange Announcement • 02 Jul 2026 20:56

Current Report (Form 8-K | Period ending 2026-07-02)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x